We are live on ! Find out more
CEMI

Chembio diagnostics, Inc.

Delisted

CEMI was delisted on the 27th of April, 2023.

76 hedge funds and large institutions have $23.7M invested in Chembio diagnostics, Inc. in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 14

81% more funds holding

Funds holding: 4276 (+34)

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

1% less call options, than puts

Call options by funds: $795K | Put options by funds: $803K

34% less capital invested

Capital invested by funds: $35.8M → $23.7M (-$12.1M)

Holders
76
Holders Change
+34
Holders Change %
+80.95%
% of All Funds
1.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
48
Increased
12
Reduced
11
Closed
14
Calls
$795K
Puts
$803K
Net Calls
-$8K
Net Calls Change
-$8K
Name Holding Trade Value Shares
Change
Change in
Stake
OMC
26
Overbrook Management Corp
New York
$169K +$494K +52,008 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$166K +$484K +50,986 New
PCM
28
Perritt Capital Management
Illinois
$162K +$474K +49,900 New
Charles Schwab
29
Charles Schwab
California
$161K +$470K +49,470 New
BFM
30
Boothbay Fund Management
New York
$152K -$255K -26,889 -37%
Morgan Stanley
31
Morgan Stanley
New York
$148K -$70.1K -7,378 -14%
HighTower Advisors
32
HighTower Advisors
Illinois
$148K +$109K +11,463 +34%
GS
33
Gagnon Securities
New York
$133K +$388K +40,882 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$128K +$374K +39,400 New
Wells Fargo
35
Wells Fargo
California
$127K +$69.5K +7,320 +23%
Neuberger Berman Group
36
Neuberger Berman Group
New York
$122K
Barclays
37
Barclays
United Kingdom
$119K +$346K +36,429 New
SC
38
Sculptor Capital
New York
$110K +$322K +33,900 New
Group One Trading
39
Group One Trading
Illinois
$108K +$314K +33,086 New
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$108K +$315K +33,164 New
Goldman Sachs
41
Goldman Sachs
New York
$107K +$312K +32,871 New
WS
42
Wedbush Securities
California
$104K +$304K +32,000 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$95K +$279K +29,379 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$94K +$275K +29,000 New
SFI
45
Susquehanna Fundamental Investments
Pennsylvania
$92K +$268K +28,200 New
LPL Financial
46
LPL Financial
California
$89K -$146K -15,329 -36%
AIP
47
ARS Investment Partners
New York
$84K -$1.93M -203,691 -89%
NIT
48
NumerixS Investment Technologies
British Columbia, Canada
$72K +$210K +22,100 New
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$72K +$211K +22,203 New
PFC
50
Phocas Financial Corp
California
$65K

CEMI Hedge Fund Activity: Q2 2020 in Review

76 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q2 2020, worth a combined $23.7M — down 34% from $35.8M a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new CEMI positions and 14 closed out — a net gain of 34 holders — while 12 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $8.84M. The largest seller was Nantahala Capital Management, cutting an estimated $11.2M.

  • 76 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q2 2020, up from 42 in Q1 2020.
  • Funds reported $23.7M of Chembio diagnostics, Inc. stock for Q2 2020, down 34% quarter-over-quarter.
  • 48 funds opened new Chembio diagnostics, Inc. positions in Q2 2020 and 14 closed out, a net change of +34 holders.
  • The largest Chembio diagnostics, Inc. buyer in Q2 2020 was BlackRock, an estimated $8.84M added.
  • The largest Chembio diagnostics, Inc. seller in Q2 2020 was Nantahala Capital Management, an estimated $11.2M sold.

Based on aggregated 13F filings for Q2 2020.